Skip to main content

CellaVision

CellaVision AB is a Swedish medical technology company specializing in automated digital microscopy for blood and body fluid analysis. The company develops analyzers, software, and reagents that automate, standardize, and streamline digital hematology processing in medical laboratories. Main revenue drivers include sales of digital microscopy hardware, software licensing, reagent consumables, and maintenance services. CellaVision serves clinical pathology laboratories, hospital diagnostic networks, and commercial laboratory testing facilities globally. The company occupies a globally dominant market position in automated digital cell morphology and hematology diagnostics. Headquartered in Lund, Sweden, CellaVision AB is listed on Nasdaq Stockholm.

13 of the funds FundTelligence covers report a position in CellaVision.

Sector
Health Care
Country
Sweden
Funds holding it
13

Funds holding CellaVision

Showing the 8 largest of 13 funds holding it.

Loading...